Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1408642481;42482;42483 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
N2AB1244537558;37559;37560 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
N2A1151834777;34778;34779 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
N2B502115286;15287;15288 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
Novex-1514615661;15662;15663 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
Novex-2521315862;15863;15864 chr2:178634525;178634524;178634523chr2:179499252;179499251;179499250
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Ig-91
  • Domain position: 33
  • Structural Position: 49
  • Q(SASA): 0.1576
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/T rs777451130 -0.431 0.784 N 0.575 0.136 0.139678290688 gnomAD-2.1.1 8.06E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.78E-05 0
S/T rs777451130 -0.431 0.784 N 0.575 0.136 0.139678290688 gnomAD-4.0.0 2.39534E-05 None None None None N None 0 0 None 0 0 None 0 0 2.96883E-05 0 3.31477E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.1219 likely_benign 0.1216 benign -0.859 Destabilizing 0.425 N 0.464 neutral N 0.436442528 None None N
S/C 0.1314 likely_benign 0.1265 benign -0.613 Destabilizing 0.993 D 0.641 neutral N 0.453440536 None None N
S/D 0.8132 likely_pathogenic 0.8058 pathogenic -0.743 Destabilizing 0.936 D 0.641 neutral None None None None N
S/E 0.6758 likely_pathogenic 0.675 pathogenic -0.619 Destabilizing 0.828 D 0.618 neutral None None None None N
S/F 0.2904 likely_benign 0.3143 benign -0.922 Destabilizing 0.006 N 0.477 neutral N 0.374002455 None None N
S/G 0.1796 likely_benign 0.1734 benign -1.207 Destabilizing 0.828 D 0.605 neutral None None None None N
S/H 0.3713 ambiguous 0.3584 ambiguous -1.635 Destabilizing 0.893 D 0.66 neutral None None None None N
S/I 0.3482 ambiguous 0.3381 benign -0.006 Destabilizing 0.543 D 0.666 neutral None None None None N
S/K 0.658 likely_pathogenic 0.636 pathogenic -0.276 Destabilizing 0.828 D 0.611 neutral None None None None N
S/L 0.1243 likely_benign 0.1333 benign -0.006 Destabilizing 0.003 N 0.469 neutral None None None None N
S/M 0.2276 likely_benign 0.2217 benign 0.069 Stabilizing 0.893 D 0.673 neutral None None None None N
S/N 0.2813 likely_benign 0.2689 benign -0.714 Destabilizing 0.828 D 0.627 neutral None None None None N
S/P 0.9881 likely_pathogenic 0.9889 pathogenic -0.256 Destabilizing 0.975 D 0.673 neutral N 0.480711742 None None N
S/Q 0.4976 ambiguous 0.4812 ambiguous -0.634 Destabilizing 0.981 D 0.668 neutral None None None None N
S/R 0.5648 likely_pathogenic 0.5495 ambiguous -0.513 Destabilizing 0.944 D 0.684 prob.neutral None None None None N
S/T 0.1208 likely_benign 0.1142 benign -0.549 Destabilizing 0.784 D 0.575 neutral N 0.443697782 None None N
S/V 0.3482 ambiguous 0.3335 benign -0.256 Destabilizing 0.329 N 0.655 neutral None None None None N
S/W 0.3332 likely_benign 0.3529 ambiguous -1.01 Destabilizing 0.985 D 0.675 neutral None None None None N
S/Y 0.1914 likely_benign 0.2058 benign -0.624 Destabilizing 0.002 N 0.465 neutral N 0.376319412 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.